BiotechTube

PEG-SD + PEG-ELS

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 20/100
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyponatremia

Conditions

Hyponatremia

Trial Timeline

Jun 1, 2010 → Sep 1, 2012

NCT ID
NCT01299779

About PEG-SD + PEG-ELS

PEG-SD + PEG-ELS is a pre-clinical stage product being developed by Bausch Health for Hyponatremia. The current trial status is completed. This product is registered under clinical trial identifier NCT01299779. Target conditions include Hyponatremia.

What happened to similar drugs?

1 of 8 similar drugs in Hyponatremia were approved

Approved (1) Terminated (4) Active (4)
✅ConivaptanAstellas PharmaApproved
🔄YM087Astellas PharmaPhase 3
❌ConivaptanAstellas PharmaPhase 3
❌Satavaptan + placeboSanofiPhase 3
🔄lixivaptan + PlaceboBiogenPhase 3
❌LixivaptanBiogenPhase 3
🔄lixivaptan + placeboBiogenPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01299779Pre-clinicalCompleted

Competing Products

9 competing products in Hyponatremia

See all competitors
ProductCompanyStageHype Score
YM087Astellas PharmaPhase 3
40
ConivaptanAstellas PharmaApproved
35
ConivaptanAstellas PharmaPhase 3
32
Tolvaptan + PlaceboJiangsu Hengrui MedicinePhase 2/3
34
Satavaptan + placeboSanofiPhase 3
32
lixivaptan + PlaceboBiogenPhase 3
37
LixivaptanBiogenPhase 3
29
lixivaptan + placeboBiogenPhase 3
37
Lixivaptan + PlaceboBiogenPhase 3
37